Allarity Therapeutics(ALLR)
$0.87-0.01 (-0.80%)
ALLR
Allarity Therapeutics financials statements
$0.87
At close:-0.01 (-0.80%)
Want to see ALLR full AI Analyst Report?
Allarity Therapeutics (ALLR) Ratios
374 Followers
Allarity Therapeutics Ratios
ALLR's free cash flow for Q3 2026 was $-2.88M. For the 2026 fiscal year, ALLR's free cash flow was increased by $0.00 and operating cash flow was $-2.88M. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Dec 23 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.13 | 2.06 | 0.14 | 0.44 | 1.03 |
| Quick Ratio | 2.13 | 2.06 | 0.14 | 0.44 | 1.03 |
| Cash Ratio | 1.74 | 1.80 | 0.01 | 0.18 | 0.94 |
| Solvency Ratio | -1.33 | -2.26 | -0.81 | -1.26 | -0.86 |
| Operating Cash Flow Ratio | -1.76 | -1.60 | -0.90 | -1.50 | -0.73 |
| Short-Term Operating Cash Flow Coverage | -10.59 | -12.85 | -9.80 | -6.36 | 0.00 |
| Net Current Asset Value | $ 9.50M | $ 11.50M | $ -12.64M | $ -7.69M | $ -9.45M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.08 | 0.06 | 0.11 | 0.26 | 0.02 |
| Debt-to-Equity Ratio | 0.14 | 0.11 | -0.47 | 1.98 | 0.06 |
| Debt-to-Capital Ratio | 0.12 | 0.10 | -0.90 | 0.66 | 0.05 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.36 | 0.05 |
| Financial Leverage Ratio | 1.86 | 1.92 | -4.31 | 7.70 | 2.64 |
| Debt Service Coverage Ratio | -6.97 | -11.91 | -6.32 | -5.50 | -40.47 |
| Interest Coverage Ratio | -68.14 | -41.72 | -34.40 | -154.54 | -41.49 |
| Debt to Market Cap | 0.09 | 0.72 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.11 | 1.25 | 0.54 | 348.97 | 228.00 |
| Net Debt to EBITDA | 1.20 | 0.75 | -0.10 | -0.10 | 0.72 |
| Profitability Margins | |||||
| Gross Profit Margin | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | -3451.87% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | -3451.87% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | -3939.06% | 0.00% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | -3509.69% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | -3509.69% | 0.00% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | -3509.69% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 100.00% | 98.47% | 100.70% | 91.35% | 100.50% |
| EBT Per EBIT | 89.10% | 91.39% | 68.99% | 51.01% | 99.85% |
| Return on Assets (ROA) | -61.51% | -108.23% | -100.33% | -110.41% | -53.69% |
| Return on Equity (ROE) | -114.28% | -207.56% | 432.61% | -849.63% | -141.87% |
| Return on Capital Employed (ROCE) | -128.26% | -230.64% | 743.12% | -1037.42% | -91.84% |
| Return on Invested Capital (ROIC) | -112.26% | -203.82% | 1704.38% | -526.97% | -91.53% |
| Return on Tangible Assets | -61.51% | -108.23% | -597.74% | -321.48% | -123.96% |
| Earnings Yield | -72.32% | -1303.87% | -1085.07% | -573.69% | -40.39% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.36 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.97 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 1020.86 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Sales Outstanding | 1020.86 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cycle | 1020.86 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -1.03 | -10.80 | -3.84 | -1482.75 | -1988.05 |
| Free Cash Flow Per Share | -1.03 | -10.98 | -3.84 | -1484.33 | -1988.05 |
| Dividend Paid and CapEx Coverage Ratio | -1852.50 | -58.23 | 0.00 | -934.28 | 0.00 |
| Capital Expenditure Coverage Ratio | -1852.50 | -58.23 | 0.00 | -934.28 | 0.00 |
| Operating Cash Flow Coverage Ratio | -10.59 | -12.85 | -9.80 | -4.50 | -13.86 |
| Operating Cash Flow to Sales Ratio | -46.31 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -95.48% | -938.74% | -1162.02% | -601.45% | -22.81% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -1.38 | -0.07 | -92.16 | -174.31 | -2475.66 |
| Price-to-Sales (P/S) Ratio | 48.53 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | 1.58 | 0.16 | -398.69 | 1480.99 | 3512.10 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -1.05 | -0.11 | -86.06 | -166.26 | -4383.48 |
| Price-to-Operating Cash Flow Ratio | -1.05 | -0.11 | -86.06 | -166.44 | -4383.48 |
| Price-to-Earnings Growth (PEG) Ratio | 0.01 | 0.00 | 0.92 | 3.69 | -23.09 |
| Enterprise Value Multiple | -0.20 | 0.67 | -97.31 | -161.93 | -2559.39 |
| Enterprise Value | 2.24M | -16.30M | 2.23M | 4.51M | 47.50M |
| EV to EBITDA | -0.20 | 0.67 | -0.20 | -0.26 | -1.84 |
| EV to Sales | 7.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | -0.15 | 0.92 | -0.18 | -0.27 | -3.16 |
| EV to Operating Cash Flow | -0.15 | 0.94 | -0.18 | -0.27 | -3.16 |
| Tangible Book Value Per Share | 0.68 | 7.35 | -3.81 | -675.29 | -1235.23 |
| Shareholders’ Equity Per Share | 0.68 | 7.35 | -0.83 | 166.64 | 2481.30 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.02 | -0.01 | 0.09 | -0.01 |
| Revenue Per Share | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -0.78 | -15.26 | -3.59 | -1415.82 | -3520.11 |
| Tax Burden | 1.00 | 0.98 | 1.01 | 0.91 | 1.01 |
| Interest Burden | 1.02 | 1.03 | 1.04 | 1.01 | 1.02 |
| Research & Development to Revenue | 20.63 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 19.76 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 1.51 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.32 | 0.71 | 1.07 | 1.05 | 0.56 |
Currency in USD

